MARKET

AMPH

AMPH

Amphastar Pharma
NASDAQ
46.72
+0.40
+0.86%
After Hours: 46.72 0 0.00% 16:20 10/04 EDT
OPEN
46.63
PREV CLOSE
46.32
HIGH
47.39
LOW
46.39
VOLUME
167.66K
TURNOVER
--
52 WEEK HIGH
65.92
52 WEEK LOW
36.56
MARKET CAP
2.27B
P/E (TTM)
14.89
1D
5D
1M
3M
1Y
5Y
1D
Amphastar Pharmaceuticals' (NASDAQ:AMPH) underlying earnings growth outpaced the solid return generated for shareholders over the past three years
Simply Wall St · 1d ago
Implied Volatility Surging for Amphastar Pharmaceuticals (AMPH) Stock Options
Barchart · 2d ago
Weekly Report: what happened at AMPH last week (0923-0927)?
Weekly Report · 5d ago
Weekly Report: what happened at AMPH last week (0916-0920)?
Weekly Report · 09/23 09:09
Weekly Report: what happened at AMPH last week (0909-0913)?
Weekly Report · 09/16 09:08
Investors Continue Waiting On Sidelines For Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Simply Wall St · 09/15 13:34
Amphastar Pharmaceuticals Offers Interesting Growth And Income Prospects
Seeking Alpha · 09/13 11:20
Amphastar: Perplexing Pipeline, Lumpy Revenues - I'm On Sidelines
Seeking Alpha · 09/12 21:42
More
About AMPH
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. Its segments include finished pharmaceutical products and API products. The finished pharmaceutical products segment manufactures, markets and distributes Primatene MIST, epinephrine, glucagon, phytonadione, lidocaine, enoxaparin, naloxone, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes RHI API and porcine insulin API for external customers and internal product development. Its pipeline has over 20 product candidates, including generic ANDAs, biosimilar, and others.

Webull offers Amphastar Pharmaceuticals Inc stock information, including NASDAQ: AMPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMPH stock methods without spending real money on the virtual paper trading platform.